The tip of the iceberg: Clinical implications of genomic sequencing projects in head and neck cancer

Andrew C. Birkeland, Megan L. Ludwig, Taha S. Meraj, J. Chad Brenner, Mark E. Prince

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head and neck squamous cell carcinoma. Despite these great advances, certain hurdles exist in translating genomic findings to clinical care. Further correlation of genetic findings to clinical outcomes, additional analyses of subgroups of head and neck cancers and follow-up investigation into genetic heterogeneity are needed. While the development of targeted therapy trials is of key importance, numerous challenges exist in establishing and optimizing such programs. This review discusses potential upcoming steps for further genetic evaluation of head and neck cancers and implementation of genetic findings into precision medicine trials.

Original languageEnglish (US)
Pages (from-to)2094-2109
Number of pages16
JournalCancers
Volume7
Issue number4
DOIs
StatePublished - Oct 21 2015
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Precision Medicine
Genetic Heterogeneity
Therapeutics
Carcinoma, squamous cell of head and neck

Keywords

  • Cancer
  • Genomic
  • HNSCC
  • Personalized medicine
  • Precision medicine
  • Targeted therapy
  • TCGA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The tip of the iceberg : Clinical implications of genomic sequencing projects in head and neck cancer. / Birkeland, Andrew C.; Ludwig, Megan L.; Meraj, Taha S.; Brenner, J. Chad; Prince, Mark E.

In: Cancers, Vol. 7, No. 4, 21.10.2015, p. 2094-2109.

Research output: Contribution to journalReview article

Birkeland, Andrew C. ; Ludwig, Megan L. ; Meraj, Taha S. ; Brenner, J. Chad ; Prince, Mark E. / The tip of the iceberg : Clinical implications of genomic sequencing projects in head and neck cancer. In: Cancers. 2015 ; Vol. 7, No. 4. pp. 2094-2109.
@article{a31a7757ff964d45834d38c6e036f87e,
title = "The tip of the iceberg: Clinical implications of genomic sequencing projects in head and neck cancer",
abstract = "Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head and neck squamous cell carcinoma. Despite these great advances, certain hurdles exist in translating genomic findings to clinical care. Further correlation of genetic findings to clinical outcomes, additional analyses of subgroups of head and neck cancers and follow-up investigation into genetic heterogeneity are needed. While the development of targeted therapy trials is of key importance, numerous challenges exist in establishing and optimizing such programs. This review discusses potential upcoming steps for further genetic evaluation of head and neck cancers and implementation of genetic findings into precision medicine trials.",
keywords = "Cancer, Genomic, HNSCC, Personalized medicine, Precision medicine, Targeted therapy, TCGA",
author = "Birkeland, {Andrew C.} and Ludwig, {Megan L.} and Meraj, {Taha S.} and Brenner, {J. Chad} and Prince, {Mark E.}",
year = "2015",
month = "10",
day = "21",
doi = "10.3390/cancers7040879",
language = "English (US)",
volume = "7",
pages = "2094--2109",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - The tip of the iceberg

T2 - Clinical implications of genomic sequencing projects in head and neck cancer

AU - Birkeland, Andrew C.

AU - Ludwig, Megan L.

AU - Meraj, Taha S.

AU - Brenner, J. Chad

AU - Prince, Mark E.

PY - 2015/10/21

Y1 - 2015/10/21

N2 - Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head and neck squamous cell carcinoma. Despite these great advances, certain hurdles exist in translating genomic findings to clinical care. Further correlation of genetic findings to clinical outcomes, additional analyses of subgroups of head and neck cancers and follow-up investigation into genetic heterogeneity are needed. While the development of targeted therapy trials is of key importance, numerous challenges exist in establishing and optimizing such programs. This review discusses potential upcoming steps for further genetic evaluation of head and neck cancers and implementation of genetic findings into precision medicine trials.

AB - Recent genomic sequencing studies have provided valuable insight into genetic aberrations in head and neck squamous cell carcinoma. Despite these great advances, certain hurdles exist in translating genomic findings to clinical care. Further correlation of genetic findings to clinical outcomes, additional analyses of subgroups of head and neck cancers and follow-up investigation into genetic heterogeneity are needed. While the development of targeted therapy trials is of key importance, numerous challenges exist in establishing and optimizing such programs. This review discusses potential upcoming steps for further genetic evaluation of head and neck cancers and implementation of genetic findings into precision medicine trials.

KW - Cancer

KW - Genomic

KW - HNSCC

KW - Personalized medicine

KW - Precision medicine

KW - Targeted therapy

KW - TCGA

UR - http://www.scopus.com/inward/record.url?scp=84944916751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944916751&partnerID=8YFLogxK

U2 - 10.3390/cancers7040879

DO - 10.3390/cancers7040879

M3 - Review article

AN - SCOPUS:84944916751

VL - 7

SP - 2094

EP - 2109

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 4

ER -